98.685.5298.2255.4Net earnings (loss) per share – basic: Continuing operations
0.840.752.542.13 Discontinued operations (2)-(0.05)-(0.05) Net earnings per share
0.840.702.542.08Net earnings (loss) per share – diluted: Continuing operations
0.830.742.492.10 Discontinued operations (2)-(0.05)-(0.05) Net earnings per share
0.830.692.492.05Shares used in the calculation of net earnings per share: Average shares outstanding - basic116.9122.1117.6122.9Average shares outstanding - diluted119.1124.5119.8124.5(1) Net orders for Q3 2010 YTD include $62 million for the cancellation of the Skandion Kliniken proton therapy system order.
(2) The operating results of ACCEL research instruments are classified as discontinued operations for all periods presented.Varian Medical Systems, Inc. and SubsidiariesCondensed Consolidated Balance Sheets(In thousands)July 1, October 1, 2011 2010 (1)(Unaudited)AssetsCurrent assetsCash and cash equivalents
520,221Accounts receivable, net581,862591,677Inventories438,483363,933Deferred tax assets and other249,185205,513Total current assets1,837,4521,681,344Property, plant and equipment598,550562,763Accumulated depreciation and amortization(315,365)(294,836)Property, plant and equipment, net283,185267,927Goodwill216,063208,451Other assets176,579166,230Total assets$
2,323,952Liabilities and Stockholders' EquityCurrent liabilitiesAccounts payable$
119,018Accrued expenses300,391287,851Deferred revenues131,012141,916Advance payments from customers316,948275,998Product warranty51,96953,233Short-term borrowings-20,000Current maturities of long-term debt11,6895,525Total current l
|SOURCE Varian Medical Systems|
Copyright©2010 PR Newswire.
All rights reserved